Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: Clinical significance of quantitative polymerase chain reaction

Medical Mycology

Volumn 52, Issue 4, 2014, Pages 427-432

  Teh, Benjamin W ^a   Azzato, Francesca A ^b   Lingaratnam, Senthil M ^a   Thursky, Karin A ^a,c   Slavin, Monica A ^a,c   Worth, Leon J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Clinical features; PCR; Pneumocystis jirovecii; Pneumonia; Quantitative

Indexed keywords

CORTICOSTEROID; FLUDARABINE; GEMCITABINE; GLYCOPROTEIN; IMMUNOSUPPRESSIVE AGENT; LENALIDOMIDE; MAJOR SURFACE GLYCOPROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; THALIDOMIDE; UNCLASSIFIED DRUG; ATOVAQUONE; CLINDAMYCIN; COTRIMOXAZOLE; PENTAMIDINE; PREDNISOLONE; PRIMAQUINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; COUGHING; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; DRUG MEGADOSE; DYSPNEA; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; QUANTITATIVE POLYMERASE CHAIN REACTION; SOLID TUMOR; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VERY ELDERLY; COMPLICATION; GENETICS; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NEOPLASM; PATHOLOGY; PNEUMONIA, PNEUMOCYSTIS; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT; ACUTE GRANULOCYTIC LEUKEMIA; BREAST CARCINOMA; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER SUSCEPTIBILITY; CHEMORADIOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GLIOMA; HOSPITAL ADMISSION; KIDNEY CARCINOMA; LEIOMYOSARCOMA; LUNG CARCINOMA; MELANOMA; METASTASIS; MOLECULAR DIAGNOSIS; MULTIMODALITY CANCER THERAPY; MYELODYSPLASTIC SYNDROME; MYELOMA; NON SMALL CELL LUNG CANCER; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION SYSTEM; QUANTITATIVE ASSAY; SARCOMA; SPUTUM; THYMUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NEOPLASMS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

PNEUMOCYSTIS JIROVECII;

EID: 84902989588     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myt020     Document Type: Article

References (18)

1. Reid AB, Chen SC, Worth LJ. Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis 2011; 24: 534-544.
2. Lu Y, Ling G, Qiang C et al. PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis. J Clin Microbiol 2011; 49: 4361-4363.
3. Oren I, Hardak E, Finkelstein R, Yigla M, Sprecher H. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia. Am J Med Sci 2011; 342: 182-185.
4. Mühlethaler K, Bögli-Stuber K, Wasmer S et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J 2012; 39: 971-978.
5. Alanio A, Desoubeaux G, Sarfati C et al. Real-time PCR assaybased strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 2011; 17: 1531-1537.
6. Worth LJ, Dooley MJ, Seymour JF et al. An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer 2005; 92: 867-872.
7. Larsen HH, Masur H, Kovacs JA et al. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 2002; 40: 490-494.
8. Gosey LL, Howard RM, Witebsky FG et al. Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol 1985; 22: 803-807.
9. Haeusler GM, SlavinMA, Seymour JF et al. Late-onset Pneumocystis jirovecii pneumonia post fludarabine, cyclophosphamide and rituximab: implications for prophylaxis. Eur J Haematol 2013; 91: 157-163.
10. Fily F, Lachkar S, Thiberville L, Favennec L, Caron F. Pneumocystis jirovecii colonization and infection among non HIVinfected patients. Med Mal Infect 2011; 41: 526-531.
11. Kovacs JA, Hiemenz JW, MacherAMet al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100: 663-671.
12. Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118: 704-711.
13. McKinnell JA, Cannella AP, Kunz DF et al. Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons. Transpl Infect Dis 2012; 14: 510-518.
14. Azoulay E, Bergeron A, Chevret S et al. Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009; 135: 655-661.
15. Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med 1995; 155: 1125-1128.
16. Matsumura Y, Ito Y, Iinuma Y et al. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2012; 18: 591-597.
17. Limper AH, Offord KP, Smith TF,MartinWJ, 2nd. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140: 1204-1209.
18. Summah H, Zhu YG, Falagas ME, Vouloumanou EK, Qu JM. Use of real-time polymerase chain reaction for the diagnosis of Pneumocystis pneumonia in immunocompromised patients: a meta-analysis. Chin Med J 2013; 126: 1965-1973.